| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Auna S.A.
$5.42
-0.52 (-9.71%)
Market Cap
163.12 M
EPS
-0.01
P/E Ratio
-
Value Trade
667.04 K
4.23 %
Week
5.86 %
1 Month
23.74 %
3 Month
10.16 %
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
-
Monthly Burn
-
Runway
-
Overview
Volume
496.19 K
52 Week Range
4.09 - 6.85
% held by Insiders
63.25 %
% held by Institutions
27.53 %
Enterprise Value
1.46 B
Total Shares
30.08 M
Short %
2.24 %
Float Shares
29.90 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in AUNA
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
AUNA Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-AUNA
Aug 18, 2026▼ -9.7%today
Auna Announces 2Q26 Financial Results
Auna, a prominent healthcare platform in Latin America, has announced its financial results for the second quarter of 2026. The results, expressed in Peruvian Soles, demonstrate the company's adherence to International Financial Reporting Standards. Auna continues to strengthen its presence in Mexico, Peru, and Colombia.
Read more →-AUNA
Jul 20, 2026Auna Announces Reporting Dates for Second Quarter 2026 Financial Results
Auna S.A. has announced the reporting dates for its Second Quarter 2026 financial results. The earnings release is set for August 18, 2026, after market close, followed by a conference call on August 19, 2026, at 8:00 a.m. ET. Auna operates in Mexico, Peru, and Colombia, enhancing its visibility in the healthcare sector.
Read more →-AUNA
May 27, 2026AUNA S.A. Soci t anonyme 6, Rue Jean Monnet L-2180 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B267590 (the Company ) Luxembourg
AUNA S.A. has issued a notice for its Annual General Meeting scheduled for June 30, 2026, in Luxembourg. The agenda includes the presentation and approval of various financial statements for the fiscal year 2025, as well as the discharge of directors and auditors. Shareholders who held shares as of May 15, 2026, will be eligible to attend and vote at the meeting. All related financial documents will be available for inspection eight days prior to the meeting.
Read more →-AUNA
May 19, 2026Auna Announces 1Q26 Financial Results
Auna has announced its financial results for the first quarter of 2026. However, the article does not provide specific details about the performance metrics or any significant developments. The lack of information limits the analysis of the company's financial health and future outlook.
Read more →-AUNA
May 19, 2026Auna Announces 1Q26 Financial Results Strong top-line growth and cash flow performance; Consolidated Adjusted EBITDA impacted by revenue adjustments; Mexico volumes and revenues growing rapidly, with Segment Adjusted EBI
Auna reported its financial results for the first quarter of 2026, showcasing a 10% increase in revenues year-over-year, bolstered by strong growth in Mexico, Peru, and Colombia. However, the company's Adjusted EBITDA decreased by 5% year-over-year, largely due to revenue adjustments and increased operating costs. Positive trends included a significant improvement in cash flow and a 19% quarter-over-quarter growth in adjusted EBITDA in Mexico. The company reaffirmed its full-year revenue and EBITDA guidance, indicating confidence in achieving its financial targets across its markets.
Read more →-AUNA
Apr 22, 2026Auna Announces the Filing of Its Form 20 F for the Fiscal Year 2025
Auna S.A. has filed its Annual Report on Form 20-F for the fiscal year ending December 31, 2025, with the SEC. The report is accessible on the SEC's website and Auna's Investor Relations page. Auna continues to expand its healthcare services across Latin America, focusing on prevention and complex diseases.
Read more →-AUNA
Apr 17, 2026Auna Reports Preliminary Key Performance Indicators for the First Quarter ended March 31, 2026
Auna has released preliminary key performance indicators for the first quarter ending March 31, 2026. The report aims to provide insights into the company's performance during this period. However, specific details regarding the indicators have not been disclosed in the article.
Read more →-AUNA
Apr 15, 2026Auna Announces Reporting Dates for First Quarter 2026 Financial Results
Auna has announced the reporting dates for its financial results for the first quarter of 2026. This announcement is part of the company's ongoing communication regarding its financial performance. The specific dates for the reporting have not been detailed in the provided text.
Read more →-AUNA
Mar 31, 2026Auna Reports Preliminary Key Performance Indicators for the First Quarter ended
Auna S.A. released preliminary key performance indicators for the first quarter ending March 31, 2026. The report indicates stable hospital metrics across emergency treatments and surgeries in various Latin American countries. Auna is set to regularly publish these metrics to enhance investor understanding. However, the preliminary nature of the data and associated risks make future performance uncertain.
Read more →-AUNA
Mar 10, 2026Auna Announces 4Q25 and FY25 Financial Results Auna Closes FY 2025 with Strong Performance in Peru and Colombia and 35% increase in Free Cash Flow Signs of Recovery in Mexico in 2026 Company Sets 12% Adjusted EBITDA Grow
Auna has announced its financial results for the fourth quarter and full year of 2025, highlighting strong performance in Peru and Colombia with a noteworthy increase in free cash flow. Despite facing challenges in Mexico during 2025, there are clear signs of recovery, with adjusted EBITDA growth anticipated for 2026. The company has made strategic adjustments in management and operations to enhance its market position. Looking forward, Auna projects a 12% revenue growth for 2026, underpinned by efforts to improve cash flow and stabilize its capital structure.
Read more →-AUNA
Feb 26, 2026Auna and EsSalud Finalize Addendum to Commence Construction of Torre Trecca in Lima, Which Will Become Peru s Largest Outpatient Facility Luxembourg
Auna S.A. has finalized an addendum with EsSalud to kick off the construction of Torre Trecca, a significant outpatient healthcare facility in Lima, Peru. The project will cover 59,000 square meters and is expected to boost healthcare capacity in the region by 20%, offering services to more than three million patients annually. Operations are anticipated to start in mid-2028, greatly reducing waiting times for millions of insured Peruvians. This endeavor aligns with Auna's strategy to improve public health services in Latin America.
Read more →-AUNA
Nov 20, 2025Auna Announces 3Q25 Financial Results Auna Delivers Solid Financial and Operating Performance in Peru and Colombia, While Advancing Key Initiatives in Mexico Luxembourg
Auna reported its financial results for Q3 2025, highlighting solid operational performance in Peru and Colombia amid difficult economic conditions. Despite a decline in financial outcomes in Mexico, the company noted improvements in surgical volumes and solid growth from its oncology services. Auna's leadership remains focused on capitalizing on growth opportunities while maintaining a path towards deleveraging. A recent USD765 million debt refinancing is expected to enhance Auna's capital structure.
Read more →-AUNA
Nov 20, 2025Auna Announces Strategic Collaboration with Sojitz to Expand Healthcare Access in Latin America Luxembourg
Auna S.A. has announced a strategic collaboration with Sojitz Corporation of America to explore joint business opportunities in the healthcare sector across Latin America, with a primary focus on Mexico. The partnership is formalized through a Memorandum of Understanding, signaling a commitment to enhance healthcare access in the region. Auna plans to invest around USD 500 million over the next three to five years to expand its integrated healthcare platform. This collaboration aims to leverage Auna's operational expertise and Sojitz's investment capabilities to develop scalable healthcare services.
Read more →-AUNA
Nov 7, 2025Auna Announces Completion of US$765 million Debt Refinancing Through successful issuance of new Senior Secured 2032 Notes and new Term Loan, Auna extends debt maturities, lowers interest expenses, and enhances short-term
Auna has successfully completed a US$765 million debt refinancing, which includes the issuance of new Senior Secured Notes and a Term Loan. This strategic move extends the company's debt maturities, lowers interest expenses, and improves liquidity, allowing Auna to pursue its growth initiatives in Latin America. The refinancing received strong interest from investors, including a significant contribution from the International Finance Corporation. Auna's management views this as a strong validation of their financial strategy and commitment to enhancing healthcare access across the region.
Read more →-AUNA
Nov 4, 2025AUNA ANNOUNCES SUCCESSFUL PRICING OF 8.750% SENIOR SECURED NOTES DUE 2032 Luxembourg
AUNA S.A. announced the successful pricing of $365 million worth of 8.750% Senior Secured Notes due in 2032. The notes will be co-issued with Oncosalud S.A.C. and will mature on November 6, 2032. Proceeds will be used to fund a tender offer for existing high-interest debt and to prepay other indebtedness. The settlement of the notes is expected to occur on November 6, 2025, pending customary closing conditions.
Read more →-AUNA
Nov 3, 2025▼ -5.4%on this newsshared move
AUNA S.A. ANNOUNCES EARLY RESULTS OF ITS CASH TENDER OFFER AND RELATED CONSENT SOLICITATION OF ANY AND ALL OF ITS OUTSTANDING 10.000% SENIOR SECURED NOTES DUE 2029 (CUSIP NOS. 05151A AA1 / L0415A AA
AUNA S.A. has announced the early results of its cash tender offer and consent solicitation for its outstanding 10.000% senior secured notes due 2029. As of the early tender date, approximately 73.39% of the notes had been validly tendered, allowing AUNA to obtain the necessary consents for proposed amendments to the indenture governing the notes. The tender offer is set to expire on November 18, 2025, unless extended. Holders of validly tendered notes may receive an early tender payment along with accrued interest, contingent upon the tender offer's successful completion.
Read more →-AUNA
Oct 28, 2025Auna S.A. and Subsidiaries Condensed Consolidated Interim Financial Statements
Auna S.A. reported its condensed consolidated interim financial statements for the period ending June 30, 2025. The company saw an increase in revenue from healthcare services, improving profits compared to the same period last year. However, there were notable losses associated with trade receivable impairments and consistently high administrative expenses. Auna's total comprehensive income showed a positive trajectory, reflecting overall financial growth despite some operational challenges.
Read more →-AUNA
Oct 28, 2025AUNA ANNOUNCES PROPOSED OFFERING OF SENIOR SECURED NOTES DUE 2032 Luxembourg
Auna S.A. has announced a proposed offering of senior secured notes due in 2032, aimed at qualified institutional buyers. The proceeds will primarily be used for a tender offer to purchase existing senior secured notes due 2029 and to prepay indebtedness. This move highlights Auna's strategy to optimize its financial structure and strengthen its position within the Latin American healthcare market. Its extensive network includes multiple healthcare facilities and a significant number of health plan members, illustrating its commitment to improving healthcare access in the region.
Read more →-AUNA
Oct 28, 2025of our report on Form 6-K/A which was furnished to the SEC on
Auna has provided a detailed discussion on its financial condition and operations as part of the Form 6-K/A report submitted to the SEC. The company highlights its commitment to expanding access to healthcare in Latin America while detailing the factors affecting its revenue. Auna also emphasizes its unique operational approach, the 'Auna Way,' which focuses on delivering high-quality, integrated healthcare solutions. However, the company acknowledges the risks associated with forward-looking statements and operational challenges posed by hospital integrations.
Read more →-AUNA
Oct 20, 2025AUNA S.A. ANNOUNCES COMMENCEMENT OF CASH TENDER OFFER AND CONSENT SOLICITATION OF ANY AND ALL OF ITS OUTSTANDING 10.000% SENIOR SECURED NOTES DUE 2029 (CUSIP NOS. 05151A AA1 / L0415A AA1) Luxembourg
AUNA S.A. has announced the commencement of a cash tender offer and consent solicitation for its outstanding 10.000% senior secured notes due 2029. This offer aims to purchase any and all of the notes, allowing for potential amendments to restrictive covenants and default provisions. The tender offer, which begins on October 20, 2025, will expire on November 18, 2025, barring extensions. Investors can receive an early tender payment if they act before October 31, 2025, demonstrating AUNA's strategic efforts to optimize its financial obligations.
Read more →-AUNA
Sep 24, 2025Auna Continues to Increase OncoMexico Network's Nationwide Presence Through Partnerships with Leading Medical Institutions Auna Intends to Meet with Debt and Equity Investors to Assess Alternatives to Raise Funds to Expa
Auna, a leading healthcare services provider in Latin America, has announced its intent to expand the OncoMexico network through strategic partnerships with top medical institutions across Mexico. The company plans to invest around US$500 million over the next three to five years to enhance its operations and improve its capital structure. Additionally, Auna has recently listed its class A shares on the Lima Stock Exchange and meets eligibility criteria for inclusion in several MSCI indices, although such inclusion is not guaranteed. The company is also assessing funding alternatives with debt and equity investors to support its growth plans.
Read more →-AUNA
Aug 19, 2025Auna Announces 2Q25 Financial Results Adjusted EBITDA increases 5% FXN YoY with all segments contributing positively to quarterly results in their local currency Luxembourg
Auna (NYSE: AUNA) reported its 2Q25 financial results, highlighting a 5% year-over-year increase in FX-neutral adjusted EBITDA, with all segments performing positively in local currency. Though net revenues fell by 2%, the company experienced growth in Mexico and Peru through effective pricing strategies and increased service volumes. Challenges included foreign exchange headwinds and lower surgical volumes impacting the overall revenue. The company remains optimistic about future growth in the healthcare sector across Latin America.
Read more →-AUNA
Jul 16, 2025Auna Common Shares Begin Trading on the Lima Stock Exchange to Strengthen Company s Regional Presence and Broaden Investor Access Luxembourg
Auna S.A., a leading healthcare services provider in Latin America, has commenced trading its common shares on the Lima Stock Exchange (BVL). This move is part of the company's strategy to enhance liquidity and broaden access for investors in the region. Auna aims to strengthen its presence in Latin America’s capital markets and elevate its eligibility for inclusion in various equity indices. The company, which already trades on the New York Stock Exchange, seeks to increase its investor base and overall market visibility.
Read more →-AUNA
Jun 30, 2025Auna provides an update from its controlling shareholder Enfoca regarding its Sponsor-level Financing Luxembourg
Auna S.A. announced that its controlling shareholder, Enfoca, has successfully refinanced its sponsor-level financing with improved economic terms, extending the maturity date to June 2027. The refinancing arrangement highlights the long-term alignment between Auna and its pre-IPO shareholders, aiding in the execution of its strategic growth initiatives. As a healthcare company operating in Mexico, Peru, and Colombia, Auna continues to prioritize prevention and high-complexity diseases within the underpenetrated markets of Latin America.
Read more →-AUNA
May 7, 2025AUNA ANNOUNCES PRICING OF ADDITIONAL 10.000% SENIOR SECURED NOTES DUE 2029 Luxembourg
Auna S.A. has announced the pricing of additional 10.000% senior secured notes due 2029, totaling $62.1 million. This offering is part of a group of previously issued notes and aims to help reduce existing indebtedness under a credit agreement. Auna's focused strategy on healthcare services in Latin America and its established network positions it as a significant player in the market. The company expressed its commitment to provide integrated healthcare solutions across underpenetrated regions.
Read more →-AUNA
May 6, 2025AUNA ANNOUNCES PROPOSED OFFERING OF ADDITIONAL 10.000% SENIOR SECURED NOTES DUE 2029 Monterrey, Mexico
Auna S.A. announced its intent to offer additional 10.000% senior secured notes due 2029 in a private offering primarily for qualified institutional buyers. This new issuance is a continuation of its existing senior secured notes and aims to raise funds for prepaying existing debt under their credit agreement. The offering is contingent upon market conditions and other factors, and proceeds will also be directed towards associated expenses. Auna, operational in Latin America, is focused on enhancing healthcare access in underpenetrated markets.
Read more →-AUNA
Apr 11, 2025AUNA ANNOUNCES THE FILING OF ITS FORM 20-F FOR FISCAL YEAR 2024 LUXEMBOURG-(BUSINESS WIRE)- Auna S.A. ("Auna" or the "Company") (NYSE: AUNA) , a Latin American healthcare company with operation
Auna S.A. has announced the filing of its Annual Report on Form 20-F for the fiscal year 2024 with the SEC. This filing, which took place on April 10, 2025, provides detailed insights into the company's financial performance and operational strategies. Auna, operating primarily in Mexico, Peru, and Colombia, focuses on delivering integrated healthcare solutions in the region. The company boasts a comprehensive network of healthcare facilities and plans, emphasizing its commitment to improving healthcare access in Latin America.
Read more →-AUNA
Mar 10, 2025Auna Announces 4Q24 and FY 2024 Financial Results Adjusted EBITDA increases 20.1% FXN in FY 2024 and Net Operating Cash Flows increase 15% YoY Luxembourg
Auna announced its financial results for the fourth quarter and full year of 2024, highlighting a significant increase in Adjusted EBITDA of 20.1% and a reduction in net losses. The company reported the emergence of net income after a significant loss in the previous year, driven by positive operations in Mexico, Peru, and a resilient performance in Colombia. Auna's balance sheet strengthened with a lower leverage ratio, but it faces challenges including regulatory issues with certain payors. The organization is focused on diversifying its payor mix and sustaining growth through strategic partnerships in oncology services.
Read more →-AUNA
Mar 7, 2025Auna Signs Exclusive Five-Year Agreement with Leading Oncology Group to Strengthen Oncology Services in Monterrey Monterrey, Mexico, March, 07, 2025 - Auna S.A. (NYSE: AUNA) ("Auna" or the "Company"), a Latin American he
Auna S.A. has signed a strategic five-year agreement with the leading oncology group Opcón Oncología in Monterrey, Mexico, to enhance its oncology services. The arrangement will bring eight distinguished physicians to Auna, improving patient care and boosting operational integration. Notably, Auna's Oncology Center is set to be one of the few fully integrated oncology facilities within the country's private healthcare sector. The partnership aligns with Auna's expansion strategy and its commitment to providing high-quality cancer care in Latin America.
Read more →-AUNA
Dec 23, 2024Auna announces the successful redemption of its 6.500% Senior Secured Notes due 2025 with the proceeds of private placement of notes Monterrey, Mexico
Auna S.A. has successfully redeemed its 6.500% Senior Secured Notes due 2025, utilizing proceeds from a private placement of USD 57.83 million in additional 10.000% Senior Secured Notes due 2029. This transaction brings the total outstanding amount of the 2029 Notes to USD 310.83 million. Auna, which operates in the healthcare sector across Mexico, Peru, and Colombia, continues to focus on providing integrated healthcare solutions in these regions. The company's actions reflect a strategic financial approach within a growing healthcare market.
Read more →-AUNA
Dec 19, 2024Auna appoints Teresa Gutierrez and Guadalupe Phillips to Its Board of Directors Monterrey, Mexico
Auna S.A. has appointed Teresa Gutierrez and Guadalupe Phillips to its Board of Directors, effective January 1, 2025. Gutierrez, with a background at Tesla and significant experience in various industries, aims to support Auna's vision of improving healthcare access in Latin America. Phillips, the CEO of ICA, brings expertise in growth and financial strategy to the board. These appointments expand Auna's board to nine members, fostering diverse leadership as the company prepares for further expansion.
Read more →-AUNA
Dec 2, 2024AUNA S.A. Soci t anonyme 6, Rue Jean Monnet L-2180 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B267590 (the Company ) Luxembourg, 20 November 2024 Convening notice to the ordinary general meeting of the share
AUNA S.A. has convened an ordinary general meeting for its shareholders scheduled for 30 December 2024. The agenda includes the approval of standalone financial statements for the fiscal year ending 31 December 2023, a reclassification of retained losses, and changes in statutory auditors due to regulatory requirements. Shareholders must confirm their attendance by 27 December 2024 and may appoint proxies if they cannot attend in person.
Read more →-AUNA
Nov 19, 2024Auna Announces 3Q24 Financial Results Adjusted EBITDA increases 23% YoY FXN, maintaining strong growth Leverage ratio decreases 0.4x to 3.7x Luxembourg
Auna has released its financial results for the third quarter of 2024, showing significant growth with a 23% increase in Adjusted EBITDA and a reduction in leverage ratio to 3.7x. The company is experiencing strong capacity utilization and revenue growth across its operations in Mexico, Peru, and Colombia. However, Auna is taking a cautious approach to growth in Colombia due to regulatory challenges, while the implementation of its AunaWay model continues to drive improvements in service delivery. The pilot program for OncoMexico shows promise as Auna prepares for future expansion in integrated oncological services.
Read more →-AUNA
Sep 3, 2024Auna appoints Executive Vice President, Strategy and Equity Capital Markets reinforcing its leadership structure Monterrey, Mexico
Auna S.A. has appointed Laurent "Lorenzo" Massart as Executive Vice President, Strategy and Equity Capital Markets to bolster its leadership team. Massart, who has extensive experience in consulting and investment banking, will oversee the Investor Relations function to enhance communication with stakeholders. The appointment reflects Auna's commitment to strengthening its executive team at a crucial time in its growth and underscores the company's focus on improving investor relations as it expands its healthcare reach in Latin America.
Read more →-AUNA
Aug 21, 2024Auna Announces 2Q24 Financial Results Adjusted EBITDA increases 31% YoY, consolidating strong results OncoMexico launched in Monterrey Luxembourg
Auna (AUNA) reported its financial results for the second quarter of 2024, highlighting a significant 31% year-over-year increase in Adjusted EBITDA, reflecting robust operational progress. The launch of OncoMexico in Monterrey marks a pivotal step in expanding their integrated oncology services in Mexico, which is expected to enhance their market presence. Despite some challenges related to foreign exchange rates, the company remains optimistic about continued growth in both Mexico and its established markets in Peru and Colombia.
Read more →-AUNA
Jul 3, 2024Auna S.A. Separate Financial Statements
Auna S.A. has released its separate financial statements for the year ending December 31, 2023, which have been audited and deemed to provide a true and fair representation of its financial position. The company reported a considerable loss of 149,998 soles for the period, raising concerns about its ongoing viability. The audit was conducted in compliance with relevant auditing standards and ethical regulations, but it did not encompass prior year figures, leaving gaps in continuity. Notably, the statements were prepared in accordance with IFRS standards, reflecting a commitment to proper accounting practices.
Read more →-AUNA
May 22, 2024Auna Announces 1Q24 Financial Results Revenue increases 20% YoY to S/1,076 million, with operating profit increasing 26% to S/182 million Adjusted EBITDA margin of 20.4% in Peruvian operations Luxembourg
Auna reported strong financial results for Q1 2024, announcing a revenue increase of 20% year-over-year amounting to S/1,076 million and an operating profit rise of 26% to S/182 million. The adjusted EBITDA margin reached 20.4% in Peru, reflecting the company's effective operational management. The firm is optimistic about its growth trajectory in 2024, expecting adjusted EBITDA to grow by at least 20% amid expanding capabilities in the healthcare sector across Latin America. Auna's performance is supported by increased patient volume and a focus on higher-margin services.
Read more →-AUNA
May 8, 2024▲ +11.1%on this news· ran to +33% by day 3
Auna Announces Reporting Dates for First Quarter 2024 Financial Results Luxembourg, Grand Duchy of Luxembourg
Auna S.A. has announced the reporting dates for its First Quarter 2024 financial results, which will be released after market close on May 22, 2024. The company, with operations in Mexico, Peru, and Colombia, emphasizes a mission to transform healthcare by enhancing access in underpenetrated Spanish-speaking regions. Auna maintains a significant healthcare network with 31 facilities and 1.3 million healthcare plans.
Read more →-AUNA
Apr 15, 2024Auna Provides Business Update Related to Colombian Operations Colombia's healthcare services regulator assumed administrative control of certain health insurance providers to oversee compliance with their payment obligat
Auna S.A. provided an update on its operations in Colombia following the temporary administrative intervention by the Colombian healthcare regulator, SUPERSALUD. The regulatory body took control of three health insurance providers to ensure compliance with payment obligations. Despite this intervention, Auna reported that it continues to receive regular payments for services provided to members of Nueva EPS and Sanitas EPS. The company reassures that it does not foresee any deterioration in payment conditions, emphasizing its commitment to monitoring the situation closely.
Read more →-AUNA
Mar 21, 2024AUNA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING OF US$360 MILLION (GROSS PROCEEDS) OF CLASS A SHARES Luxembourg, Grand Duchy of Luxembourg
AUNA has priced its initial public offering of 30,000,000 Class A shares at $12.00 per share, expected to raise $360 million in gross proceeds. The company plans to utilize the net proceeds primarily to acquire a 21.2% interest in Auna Salud S.A.C. and to address general corporate purposes. The shares will be listed on the New York Stock Exchange under the ticker symbol AUNA, with trading set to commence on March 22, 2024. The offering has met regulatory requirements and is backed by a group of prominent underwriters.
Read more →-AUNA
Dec 12, 2023AUNA S.A. ANNOUNCES EXPIRATION AND FINAL RESULTS OF 81.13% OF THE TOTAL PRINCIPAL AMOUNT OUTSTANDING TENDERED FOR THE PREVIOUSLY ANNOUNCED EXCHANGE OFFER OF ANY AND ALL OF ITS OUTSTANDING 6.500% SENIOR NOTES DUE 2025 FOR NEW NOTES AND RELATED CONSENT SOLICITATION Auna S.A. ("Auna," the "Company" or "we"), one of the largest players in the Latin American healthcare industry and with presence in Mexico, Colombia ...
Auna S.A. has announced the successful expiration of its exchange offer for its 6.500% Senior Notes due 2025, with 81.13% of the total principal amount tendered. The company will issue new 10.000% Senior Secured Notes due 2029, with the settlement expected on December 18, 2023. This move is part of Auna's strategy to enhance its financial structure.
Read more →-AUNA
Nov 28, 2023AUNA S.A. ANNOUNCES EARLY PARTICIPATION DEADLINE RESULTS FOR THE PREVIOUSLY ANNOUNCED EXCHANGE OFFER OF ANY AND ALL OF ITS OUTSTANDING 6.500% SENIOR NOTES DUE 2025 FOR NEW NOTES AND RELATED CONSENT SOLICITATION Auna S.A. ("Auna," the "Company" or "we"), one of the largest players in the Latin American healthcare industry and with presence in Mexico, Colombia ...
Auna S.A. has announced that as of November 28, 2023, 80.26% of its outstanding 6.500% Senior Notes due 2025 have been validly tendered for exchange for new 10.000% Senior Secured Notes due 2029. The company has satisfied the Minimum Exchange Condition required for the exchange offer and is set to execute amendments to the existing notes. The exchange offer will expire on December 12, 2023.
Read more →-AUNA
Nov 10, 2023AUNA S.A. ANNOUNCES EXCHANGE OFFER OF ANY AND ALL OF ITS OUTSTANDING 6.500% SENIOR NOTES DUE 2025 FOR NEW NOTES AND RELATED CONSENT SOLICITATION Auna S.A. ("Auna," the "Company" or "we"), one of the largest players in the Latin American healthcare industry and with presence in Mexico, Colombia ...
Auna S.A. has initiated an exchange offer for its outstanding 6.500% Senior Notes due 2025, proposing to exchange them for newly issued 10.000% Senior Secured Notes due 2029. The exchange offer includes a consent solicitation for amendments to the existing indenture. Eligible holders can receive total consideration if they participate by the early participation deadline. The exchange offer is subject to certain conditions, including the successful closing of a new term loan.
Read more →-AUNA
Oct 25, 2023AUNA PROVIDES UPDATE ON CAPITAL STRUCTURE INITIATIVES Auna S.A. ("Auna" or the "Company") intends to confidentially submit a draft registration statement on Form F-1 to the U.S. Securities and Exchange...
Auna S.A. intends to confidentially submit a draft registration statement on Form F-1 to the SEC for an initial public offering of its Class A shares in the U.S. The IPO is part of Auna's strategy to enhance its capital structure and expand in Spanish-speaking Latin America. The timing of the offering will depend on market conditions and SEC review.
Read more →-AUNA
Sep 29, 2023FITCH RATINGS REAFFIRMS AUNA'S CREDIT RATING Auna S.A. ("Auna" or the "Company"), one of the largest players in the Latin American healthcare industry and with operations in Mexico, Colombia and ...
Fitch Ratings has reaffirmed Auna S.A.'s credit rating at 'B' with a positive outlook. The rating reflects Auna's strong market position and improved financial performance, aided by recent acquisitions in Colombia and Mexico. However, challenges include limited financial flexibility and the need to refinance significant senior notes due in 2025. Auna is actively pursuing this refinancing ahead of the second quarter of 2024.
Read more →-AUNA
Sep 13, 2023AUNA S.A. Announces Conference Call and Webcast to Discuss Second Quarter Financial Results Auna S.A. ("Auna" or the "Company"), one of the largest players in the Latin American healthcare industry and with presence in Mexico, Colombia, and...
Auna S.A. has announced a conference call scheduled for September 21, 2023, to discuss its second quarter financial results. The call will feature the Executive Chairman and the CFO, providing insights into the company's performance. Auna, a major healthcare provider in Latin America, continues to grow its operations and member services.
Read more →-AUNA
Aug 29, 2023AUNA APPOINTS ANASOFIA SANCHEZ JUAREZ TO ITS BOARD OF DIRECTORS Auna S.A. ("Auna" or the "Company"), one of the largest players in Latin America's healthcare industry, with presence in Mexico, Colombia and Peru,...
Auna S.A. has appointed Anasofia Sanchez Juarez as an Independent Board member, enhancing its governance structure. Sanchez, with a strong background in technology and marketing, aims to leverage her expertise to drive innovation in Auna's healthcare services. This appointment increases the independent director presence on the board to 50%, reflecting Auna's commitment to effective governance.
Read more →Competitive Position
How AUNA ranks across every disease it competes inCompetitive Position is a premium feature
See how AUNA ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial